S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
The Top 3 Stocks to Buy in December
Marvell Technology (NASDAQ:MRVL) a Buy After its Marvelous Q3
Time is no ally as Dems strain to finish Biden's $2T bill
Learn Technical Analysis Skills to Master the Stock Market
Trump media partner says it has lined up $1B in capital
Marvell Technology (NASDAQ:MRVL) a Buy After its Marvelous Q3
Increased Demand for Immigration to the United States
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
The Top 3 Stocks to Buy in December
Marvell Technology (NASDAQ:MRVL) a Buy After its Marvelous Q3
Time is no ally as Dems strain to finish Biden's $2T bill
Learn Technical Analysis Skills to Master the Stock Market
Trump media partner says it has lined up $1B in capital
Marvell Technology (NASDAQ:MRVL) a Buy After its Marvelous Q3
Increased Demand for Immigration to the United States
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
The Top 3 Stocks to Buy in December
Marvell Technology (NASDAQ:MRVL) a Buy After its Marvelous Q3
Time is no ally as Dems strain to finish Biden's $2T bill
Learn Technical Analysis Skills to Master the Stock Market
Trump media partner says it has lined up $1B in capital
Marvell Technology (NASDAQ:MRVL) a Buy After its Marvelous Q3
Increased Demand for Immigration to the United States
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
The Top 3 Stocks to Buy in December
Marvell Technology (NASDAQ:MRVL) a Buy After its Marvelous Q3
Time is no ally as Dems strain to finish Biden's $2T bill
Learn Technical Analysis Skills to Master the Stock Market
Trump media partner says it has lined up $1B in capital
Marvell Technology (NASDAQ:MRVL) a Buy After its Marvelous Q3
Increased Demand for Immigration to the United States
CVE:MDP

Medexus Pharmaceuticals Stock Chart and Price History

C$7.75
-0.40 (-4.91%)
(As of 06/16/2021)
Add
Compare
Today's Range
C$7.70
▼
C$8.14
50-Day Range
C$7.75
▼
C$7.75
52-Week Range
C$2.80
▼
C$9.75
Volume
40,981 shs
Average Volume
68,619 shs
Market Capitalization
C$148.54 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A

Medexus Pharmaceuticals (CVE:MDP) Price Performance

5 Day
Performance
0.00%

1 Month
Performance
0.00%

3 Month
Performance
0.00%

Year-To-Date
Performance
+13.14%

1 Year
Performance
+40.65%


Medexus Pharmaceuticals (CVE MDP) Stock Chart for Saturday, December, 4, 2021

Charts Provided by TradingView.

Medexus Pharmaceuticals (CVE:MDP) Price History

Export to Excel
DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
12/03/2021C$7.75C$7.75C$8.14C$7.7040,981 shsC$148.54 million
12/02/2021C$7.75C$7.75C$8.14C$7.7040,981 shsC$148.54 million
12/01/2021C$7.75C$7.75C$8.14C$7.7040,981 shsC$148.54 million
11/30/2021C$7.75C$7.75C$8.14C$7.7040,981 shsC$148.54 million
11/29/2021C$7.75C$7.75C$8.14C$7.7040,981 shsC$148.54 million
11/26/2021C$7.75C$7.75C$8.14C$7.7040,981 shsC$148.54 million
11/25/2021C$7.75C$7.75C$8.14C$7.7040,981 shsC$148.54 million
11/24/2021C$7.75C$7.75C$8.14C$7.7040,981 shsC$148.54 million
11/23/2021C$7.75C$7.75C$8.14C$7.7040,981 shsC$148.54 million
11/22/2021C$7.75C$7.75C$8.14C$7.7040,981 shsC$148.54 million
11/19/2021C$7.75C$7.75C$8.14C$7.7040,981 shsC$148.54 million
11/18/2021C$7.75C$7.75C$8.14C$7.7040,981 shsC$148.54 million
11/17/2021C$7.75C$7.75C$8.14C$7.7040,981 shsC$148.54 million
11/16/2021C$7.75C$7.75C$8.14C$7.7040,981 shsC$148.54 million
11/15/2021C$7.75C$7.75C$8.14C$7.7040,981 shsC$148.54 million
11/12/2021C$7.75C$7.75C$8.14C$7.7040,981 shsC$148.54 million
11/11/2021C$7.75C$7.75C$8.14C$7.7040,981 shsC$148.54 million
11/10/2021C$7.75C$7.75C$8.14C$7.7040,981 shsC$148.54 million
11/09/2021C$7.75C$7.75C$8.14C$7.7040,981 shsC$148.54 million
11/08/2021C$7.75C$7.75C$8.14C$7.7040,981 shsC$148.54 million
11/05/2021C$7.75C$7.75C$8.14C$7.7040,981 shsC$148.54 million
11/04/2021C$7.75C$7.75C$8.14C$7.7040,981 shsC$148.54 million
11/03/2021C$7.75C$7.75C$8.14C$7.7040,981 shsC$148.54 million
11/02/2021C$7.75C$7.75C$8.14C$7.7040,981 shsC$148.54 million
11/01/2021C$7.75C$7.75C$8.14C$7.7040,981 shsC$148.54 million
10/29/2021N/AC$7.75C$8.14C$7.7040,981 shsC$148.54 million
10/18/2021C$7.75C$7.75C$8.14C$7.7040,981 shsC$148.54 million
10/15/2021C$7.75C$7.75C$8.14C$7.7040,981 shsC$148.54 million
10/14/2021C$7.75C$7.75C$8.14C$7.7040,981 shsC$148.54 million
10/13/2021C$7.75C$7.75C$8.14C$7.7040,981 shsC$148.54 million
10/12/2021C$7.75C$7.75C$8.14C$7.7040,981 shsC$148.54 million
10/11/2021C$7.75C$7.75C$8.14C$7.7040,981 shsC$148.54 million
10/08/2021C$7.75C$7.75C$8.14C$7.7040,981 shsC$148.54 million
10/07/2021C$7.75C$7.75C$8.14C$7.7040,981 shsC$148.54 million
10/06/2021C$7.75C$7.75C$8.14C$7.7040,981 shsC$148.54 million
10/05/2021C$7.75C$7.75C$8.14C$7.7040,981 shsC$148.54 million
10/04/2021C$7.75C$7.75C$8.14C$7.7040,981 shsC$148.54 million
10/01/2021C$7.75C$7.75C$8.14C$7.7040,981 shsC$148.54 million
09/30/2021C$7.75C$7.75C$8.14C$7.7040,981 shsC$148.54 million
09/29/2021C$7.75C$7.75C$8.14C$7.7040,981 shsC$148.54 million
09/28/2021C$7.75C$7.75C$8.14C$7.7040,981 shsC$148.54 million
09/27/2021C$7.75C$7.75C$8.14C$7.7040,981 shsC$148.54 million
09/24/2021C$7.75C$7.75C$8.14C$7.7040,981 shsC$148.54 million
09/23/2021C$7.75C$7.75C$8.14C$7.7040,981 shsC$148.54 million
09/22/2021C$7.75C$7.75C$8.14C$7.7040,981 shsC$148.54 million
09/21/2021C$7.75C$7.75C$8.14C$7.7040,981 shsC$148.54 million
09/20/2021C$7.75C$7.75C$8.14C$7.7040,981 shsC$148.54 million
09/17/2021C$7.75C$7.75C$8.14C$7.7040,981 shsC$148.54 million
09/16/2021C$7.75C$7.75C$8.14C$7.7040,981 shsC$148.54 million
09/15/2021C$7.75C$7.75C$8.14C$7.7040,981 shsC$148.54 million
09/14/2021C$7.75C$7.75C$8.14C$7.7040,981 shsC$148.54 million
09/13/2021C$7.75C$7.75C$8.14C$7.7040,981 shsC$148.54 million
09/10/2021C$7.75C$7.75C$8.14C$7.7040,981 shsC$148.54 million
09/09/2021C$7.75C$7.75C$8.14C$7.7040,981 shsC$148.54 million
09/08/2021C$7.75C$7.75C$8.14C$7.7040,981 shsC$148.54 million
09/07/2021C$7.75C$7.75C$8.14C$7.7040,981 shsC$148.54 million
09/06/2021C$7.75C$7.75C$8.14C$7.7040,981 shsC$148.54 million
09/03/2021C$7.75C$7.75C$8.14C$7.7040,981 shsC$148.54 million
This page was last updated on 12/4/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.